Article · Journal · 2026

Safety and efficacy of pociredir in adults with severe sickle cell disease and hydroxyurea intolerance or unresponsiveness: results from the phase 1b PIONEER study

Journal of sickle cell disease.

Citations: 0from other works
Field-weighted impact: 0.001.00 is the world average for its field and year
Among its field: 50th percentileby citations, against works of its field and year
Authors: 14from 13 institutions

Authors

14 authors across 13 institutions in 3 countries